In August 2019 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Paul Kariuki Mwangi after his sample tested positive for the prohibtied substance Methylprednisolone.
After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and the case was settled by the Kenyan Sports Disputes Tribunal based on the written submissions of the parties
The Athlete admitted the violation and denied the intentional use of the substance. He explained with medical information that he had used prescribed medication as treatment for his allergies and was unaware that he needed a TUE. He acknowledged that he didn't check his medication before using nor informed his doctor that he is an athlete subjected to doping control.
Considering the evidence in this case the Panel accepts that the violation was not intentional and considers that he gave a prompt admission and established the source of the positive test. Further the Panel finds that he acted negligently since he failed to check his medication and neither informed his doctor that he is an athlete.
Therefore the Tribunal decides to impose a 2 year period of ineligibility on the Athlete starting on the date of the provisional suspension, i.e. on 7 August 2019.
